UK markets closed
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • FTSE 250

    19,123.71
    +430.73 (+2.30%)
     
  • AIM

    896.27
    +10.41 (+1.18%)
     
  • GBP/EUR

    1.1618
    -0.0028 (-0.24%)
     
  • GBP/USD

    1.2270
    +0.0009 (+0.07%)
     
  • BTC-GBP

    17,339.86
    +23.54 (+0.14%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • DOW

    31,500.68
    +823.32 (+2.68%)
     
  • CRUDE OIL

    107.06
    +2.79 (+2.68%)
     
  • GOLD FUTURES

    1,828.10
    -1.70 (-0.09%)
     
  • NIKKEI 225

    26,491.97
    +320.72 (+1.23%)
     
  • HANG SENG

    21,719.06
    +445.19 (+2.09%)
     
  • DAX

    13,118.13
    +205.54 (+1.59%)
     
  • CAC 40

    6,073.35
    +190.02 (+3.23%)
     

EQUASENS (Pharmagest Interactive): ANNUAL ORDINARY GENERAL MEETING PRELIMINARY NOTICE

·1-min read
PHARMAGEST INTERACTIVE
PHARMAGEST INTERACTIVE

Villers-lès-Nancy, 30 May 2022 - 6:00 p.m. (CET)

PRESS RELEASE

ANNUAL ORDINARY GENERAL MEETING

PRELIMINARY NOTICE

EQUASENS (formally PHARMAGEST INTERACTIVE) hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 28, 2022 at 5.00 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud).

The agenda and the draft resolutions were published in the BALO n°60 (Bulletin des Annonces Légales et Obligatoires) of May 20, 2022 (www.journal-officiel.gouv.fr) and on the company’s website (www.equasens.com).

Pursuant to article R.22-10-23 of the French commercial code, EQUASENS will publish the documents prescribed by this article 21 days prior to the meeting on its website
https://equasens.com/investisseurs/assemblee-generale/.

For the purpose of communications between the Company and its shareholders, it is strongly recommended that requests or documents be sent, in priority, by email, to the following address: actionnaires@equasens.com.

About Equasens Group:

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment A
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable

Included under the European Rising Tech label.
Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR0012882389 - Ticker Code to be confirmed

For all the latest news on Equasens Group go to www.equasens.com

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@equasens.com

Media Relations:
FIN’EXTENSO - Isabelle APRILE

Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting